Holen Sie sich die Stockscreener-App
30.00
3.16%
0.92
Vorhandelsmarkt:
29.10
-0.90
-3.00%
Schlusskurs vom Vortag:
$29.08
Offen:
$29.32
24-Stunden-Volumen:
875.91K
Relative Volume:
1.38
Marktkapitalisierung:
$2.28B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.16M
KGV:
-23.62
EPS:
-1.2702
Netto-Cashflow:
$-69.06M
1W Leistung:
+7.26%
1M Leistung:
+4.64%
6M Leistung:
-14.82%
1J Leistung:
+0.00%
1-Tages-Spanne:
$29.26
$30.35
1-Wochen-Bereich:
$28.40
$30.35
52-Wochen-Spanne:
$25.77
$50.23
Cg Oncology Inc Stock (CGON) Company Profile
Firmenname
Cg Oncology Inc
Sektor
Branche
Telefon
(949) 419-6203
Adresse
400 SPECTRUM CENTER DRIVE, IRVINE
Vergleichen Sie CGON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
30.00 | 2.28B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-09-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-28 | Eingeleitet | ROTH MKM | Buy |
| 2024-06-28 | Eingeleitet | BofA Securities | Buy |
| 2024-02-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Eingeleitet | Goldman | Neutral |
| 2024-02-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cg Oncology Inc Aktie (CGON) Neueste Nachrichten
Oncolytic Virus Cancer Therapy Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | CG Oncology, Targovax, Transgene, Istari Oncology, Targovax, Oncolytics Biotech - The Globe and Mail
Oncolytic Virus Cancer Therapy Pipeline 2024: Therapies, MOA - openPR
This CG Oncology Insider Reduced Their Stake By 16% - Simply Wall St
Cg Oncology Inc (CGON) Volatility Hits 4.53%: What Good Investors Need To Be Aware Of - Stocks Register
Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect? - Yahoo Finance
Cg oncology director Leonard Post sells shares worth $29,660 By Investing.com - Investing.com Australia
Cg oncology director Leonard Post sells shares worth $29,660 - Investing.com India
CG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 Shares - MarketBeat
CG Oncology (NASDAQ:CGON) Earns “Buy” Rating from HC Wainwright - Defense World
CG Oncology amends executive compensation agreements By Investing.com - Investing.com Canada
CG Oncology amends executive compensation agreements - Investing.com India
A First Take On CG Oncology (NASDAQ:CGON) - Seeking Alpha
CG Oncology's (CGON) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Pfizer study impact on CG Oncology to be minimal, says H.C. Wainwright - TipRanks
CG Oncology (NASDAQ:CGON) Research Coverage Started at TD Cowen - Defense World
TD Cowen Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - MSN
CG Oncology (NASDAQ:CGON) Stock Price Up 7.5%Time to Buy? - MarketBeat
TD Cowen initiates CG Oncology stock with Buy rating By Investing.com - Investing.com Canada
CG Oncology (NASDAQ:CGON) Now Covered by TD Cowen - MarketBeat
TD Cowen initiates CG Oncology stock with Buy rating - Investing.com
CG Oncology, Inc. (NASDAQ:CGON) Short Interest Down 5.3% in December - MarketBeat
CG Oncology (NASDAQ:CGON) Stock Price Down 6.9%Time to Sell? - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of “Buy” by Brokerages - Defense World
Head-To-Head Analysis: Atyr PHARMA (NASDAQ:ATYR) versus CG Oncology (NASDAQ:CGON) - Defense World
CG Oncology : Reports Third Quarter 2024 Financial Results and Provides Business Updates Form 8 K - Marketscreener.com
CG Oncology (NASDAQ:CGON) Shares Up 2.5%Still a Buy? - MarketBeat
Comparing Tarsus Pharmaceuticals (NASDAQ:TARS) and CG Oncology (NASDAQ:CGON) - Defense World
Geode Capital Management LLC Has $40.70 Million Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Geode Capital Management LLC Increases Stake in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Barclays PLC Increases Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 2,503 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Shares Down 4.3%Time to Sell? - MarketBeat
CG Oncology Enters Oversold Territory (CGON) - Nasdaq
State Street Corp Raises Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
State Street Corp Acquires 717,722 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock By Investing.com - Investing.com Australia
Franklin Resources Inc. Has $46.16 Million Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Song Hong Fang sells shares worth $19.6 million By Investing.com - Investing.com South Africa
Cg oncology director Song Hong Fang sells shares worth $19.6 million - Investing.com Canada
Hong Fang Song Sells 700,000 Shares of CG Oncology, Inc. (NASDAQ:CGON) Stock - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock - Investing.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares - Marketscreener.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Marketscreener.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase - EIN News
CG Oncology Raises $238M in Successful Public Offering at $28 Per Share - StockTitan
CG Oncology's SWOT analysis: cretostimogene's potential reshapes NMIBC stock outlook - Investing.com
CG Oncology's SWOT analysis: cretostimogene's potential reshapes NMIBC stock outlook By Investing.com - Investing.com South Africa
Jane Street Group LLC Buys 138,400 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Finanzdaten der Cg Oncology Inc-Aktie (CGON)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):